442 related articles for article (PubMed ID: 15324713)
21. New and emerging treatments for irritable bowel syndrome and functional dyspepsia.
Talley NJ
Expert Opin Emerg Drugs; 2002 May; 7(1):91-8. PubMed ID: 15989538
[TBL] [Abstract][Full Text] [Related]
22. Bacterial concepts in irritable bowel syndrome.
Lin HC; Pimentel M
Rev Gastroenterol Disord; 2005; 5 Suppl 3():S3-9. PubMed ID: 17713456
[TBL] [Abstract][Full Text] [Related]
23. Nuances in treating irritable bowel syndrome.
Frissora CL
Rev Gastroenterol Disord; 2007; 7(2):89-96. PubMed ID: 17597676
[TBL] [Abstract][Full Text] [Related]
24. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.
Gershon MD
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849
[TBL] [Abstract][Full Text] [Related]
25. [Recent insights into the pathogenesis of abdominal symptoms in functional bowel disorders].
Cervio E; Rondanelli M; Balestra B; Dellabianca A; Agazzi A; Giacosa A; Tonini M
Recenti Prog Med; 2007 Feb; 98(2):69-73. PubMed ID: 17439064
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological treatment of irritable bowel syndrome--from concept to sales.
Kamm MA
Eur J Surg Suppl; 2002; (587):10-5. PubMed ID: 16144196
[TBL] [Abstract][Full Text] [Related]
27. Treatment of irritable bowel syndrome: sex and gender specific aspects.
Voß U; Lewerenz A; Nieber K
Handb Exp Pharmacol; 2012; (214):473-97. PubMed ID: 23027463
[TBL] [Abstract][Full Text] [Related]
28. Review article: probiotics and prebiotics in irritable bowel syndrome.
Spiller R
Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993
[TBL] [Abstract][Full Text] [Related]
29. Tegaserod: a novel, selective 5-HT4 receptor partial agonist for irritable bowel syndrome.
Beglinger C
Int J Clin Pract; 2002; 56(1):47-51. PubMed ID: 11831835
[TBL] [Abstract][Full Text] [Related]
30. Aminosalicylates and other anti-inflammatory compounds for irritable bowel syndrome.
Barbara G; Stanghellini V; Cremon C; De Giorgio R; Fronzoni L; Serra M; Corinaldesi R
Dig Dis; 2009; 27 Suppl 1():115-21. PubMed ID: 20203507
[TBL] [Abstract][Full Text] [Related]
31. Therapy options in irritable bowel syndrome.
Enck P; Junne F; Klosterhalfen S; Zipfel S; Martens U
Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1402-11. PubMed ID: 21389791
[TBL] [Abstract][Full Text] [Related]
32. Update on irritable bowel syndrome and gender differences.
Heitkemper MM; Jarrett ME
Nutr Clin Pract; 2008; 23(3):275-83. PubMed ID: 18595860
[TBL] [Abstract][Full Text] [Related]
33. A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation.
Malagelada JR
Int J Clin Pract; 2006 Jan; 60(1):57-63. PubMed ID: 16409429
[TBL] [Abstract][Full Text] [Related]
34. Clinical studies on alleviating the symptoms of irritable bowel syndrome.
Kajander K; Korpela R
Asia Pac J Clin Nutr; 2006; 15(4):576-80. PubMed ID: 17077079
[TBL] [Abstract][Full Text] [Related]
35. Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome.
Hertig VL; Cain KC; Jarrett ME; Burr RL; Heitkemper MM
Nurs Res; 2007; 56(6):399-406. PubMed ID: 18004186
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease.
Spiller R
Neurogastroenterol Motil; 2007 Aug; 19 Suppl 2():25-31. PubMed ID: 17620085
[TBL] [Abstract][Full Text] [Related]
37. Alterations of sensori-motor functions of the digestive tract in the pathophysiology of irritable bowel syndrome.
Delvaux M
Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):747-71. PubMed ID: 15324712
[TBL] [Abstract][Full Text] [Related]
38. [Tegaserod in treatment of women with irritable bowel syndrome].
Munck LK; Ainsworth MA
Ugeskr Laeger; 2007 Jun; 169(23):2190-2. PubMed ID: 17592683
[TBL] [Abstract][Full Text] [Related]
39. The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome.
Grover M; Herfarth H; Drossman DA
Clin Gastroenterol Hepatol; 2009 Jan; 7(1):48-53. PubMed ID: 18848909
[TBL] [Abstract][Full Text] [Related]
40. Antidepressants in the treatment of irritable bowel syndrome and visceral pain syndromes.
Crowell MD; Jones MP; Harris LA; Dineen TN; Schettler VA; Olden KW
Curr Opin Investig Drugs; 2004 Jul; 5(7):736-42. PubMed ID: 15298070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
